BRAIN Biotech AG (BNN)
XETR
Closed
Oct 7, 2026
Day's Range
2.7652 wk Range
2.05Overview - BNN - BRAIN Biotech AG
Key Statistics
Valuation
Enterprise Value
61.32M
P/E (Trailing)
‪-5.27‬
P/E (Forward)
‪-7.12‬
PEG Ratio
‪-0.01‬
Price / Sales (TTM)
‪1.35‬
Price / Book
‪-8.74‬
EV / EBITDA
‪-11.91‬
Profitability
Gross Margin
‪58.11%‬
Profit Margin
‪-30.32%‬
Operating Margin
‪-19.96%‬
Return on Assets
‪-8.00%‬
Return on Equity
‪-637.80%‬
Ownership
Shares Outstanding
21.84M
Float
9.09M
Held by Insiders
‪58.40%‬
Held by Institutions
‪8.49%‬
Price stats
Beta
‪0.61‬
50-Day Avg
‪2.79‬
200-Day Avg
‪2.67‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
3 analysts
Average price target
‪€ 5.50‬Market Cap - BNN - BRAIN Biotech AG
Peers - BNN - BRAIN Biotech AG
Peer Comparison
Compared with companies in Specialty Chemicals listed on XETR.
- BNNXETRBRAIN Biotech AG62.26MMarket Cap+20.00%52-week change-5.28P/E (Trailing)‪-30.32%‬Profit Margin
- AILXETRAir Liquide S.A.108.55BMarket Cap+0.19%52-week change30.59P/E (Trailing)‪13.08%‬Profit Margin
- AMCXETRAlbemarle Corporation11.48BMarket Cap+23.62%52-week change405.58P/E (Trailing)‪3.79%‬Profit Margin
- ACT0XETRAlzchem Group AG1.64BMarket Cap+1.53%52-week change24.31P/E (Trailing)‪11.41%‬Profit Margin
- 2HRAXETRH&R GmbH & Co. KGaA276.18MMarket Cap+33.02%52-week change106.00P/E (Trailing)‪0.19%‬Profit Margin
Profile Summary - BNN - BRAIN Biotech AG
About
BRAIN Biotech AG is a leading European technology company specializing in industrial biotechnology. Founded in 1993 and headquartered in Zwingenberg, Germany, it develops and commercializes bio-based products and solutions, including bioactive natural compounds, proprietary enzymes, high-performance microorganisms,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
